Quarry LP’s Pliant Therapeutics PLRX Stock Holding History

Quarry LP’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-104	Closed	-$1.12K	–	1983
2024 Q2	$1.12K	Buy	+104	New	+$1.34K	﹤0.01%	1697

Other funds holding PLRX

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Quarry LP's PLRX Position: Q3 2024 in Review

Quarry LP sold out of Pliant Therapeutics (PLRX) in Q3 2024, closing a stake of 104 shares — an estimated $1.12K sold.

Quarry LP first reported a position in PLRX in Q2 2024 and held it in 1 quarter. The position peaked at $1.12K in Q2 2024. 151 funds tracked by Wall St. Rank hold PLRX as of Q3 2024.

Quarry LP reported no remaining Pliant Therapeutics position as of Q3 2024 after selling out during the quarter.
Quarry LP sold 104 Pliant Therapeutics shares in Q3 2024, an estimated $1.12K.
Quarry LP first reported a position in Pliant Therapeutics in Q2 2024 and held it in 1 quarter.
Quarry LP's Pliant Therapeutics position peaked at $1.12K in Q2 2024.
151 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2024.

Based on Quarry LP's 13F filing for Q3 2024, filed 14 Nov 2024.